Skip to content
OpenCapital
Get started
Income StatementBalance SheetCash FlowSegments
ResMed logo

ResMed Income Statement

Revenue, expenses, and profitability over time

ResMed generated $5.7B in trailing twelve-month revenue, up 0.1% year-over-year. Net income was $1.5B with a 26.8% net margin. Gross margin stands at 62.29% and operating margin at 34.47%. Diluted EPS is $10.36, which grew 0.1% year-over-year. Based on the Q1 2026 filing.

Total Revenue (TTM)$5.7BGross Profit (TTM)$3.5BOperating Income (TTM)$1.9BNet Income (TTM)$1.5BEps Diluted (TTM)$10.36
Latest FilingQ1 2026
Report Date2026-04-30
Market Cap$27.9B
P/E Ratio18.41
ROE25.19%

Operating Expenses

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Depreciation and amortization$7.6M$7.4M$8.2M$7.8M$7.8M$7.9M
Amortization of acquired intangible assets$11M$10.9M$12.8M$12M$11.8M$11.2M

Other Income & Expense

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income from equity method investments$1.1M$335K$2.7M$1.5M$1.5M$1.7M
Net investment gains (losses)-$1.4M-$5.6M-$237K-$6.2M$306K-$10.1M
Interest Income (Expense), Nonoperating-$775K$793K$15.9M$8.8M$7.9M$12.3M

Net Income

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Net income$344.6M$365M$376.1M$348.5M$392.6M$398.7M

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Gain on insurance recoveries$0$0$0$0$0—
Income Taxes Paid, Net$43.2M——$61.9M$16.2M—
Accounts payable and other current liabilities$122M——$7.6M$49.1M—
Increase (Decrease) in Accounts Receivable$57.5M——-$30M$5.2M—
Increase (Decrease) in Inventories-$8.9M——$14.7M$32.1M—
Increase (Decrease) in Prepaid Expense and Other Assets$16.2M——-$2.3M-$47M—
Interest Paid, Excluding Capitalized Interest, Operating Activity$5.9M——$6.9M$6.9M—
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation-$393.3M——-$230.3M-$163.9M—
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation-$46.5M——-$52.6M-$133.7M—
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation$440.1M——$457.3M$538.8M—
Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1$2.3M———$6.3M—
Payments for Repurchase of Common Stock$50M——$150M$100M—
Payments of Dividends$70.6M——$87.8M$77.6M—
Payment related to business acquisition$19.7M——$522K$138.6M—
Payments to Acquire Businesses, Net of Cash Acquired$19.7M——$522K$138.6M—
Payments to Acquire Intangible Assets$1.4M——$2.8M$10.8M—
Payments to Acquire Investments$3.1M——$2.2M$2M—
Payments to Acquire Property, Plant, and Equipment$24.9M——$43M$30.6M—
Proceeds from Issuance of Common Stock$27.7M——$8.2M$30.2M—
Repayments of Long-Term Debt$300M——$0$5M—
Stock-based compensation$21.4M——$21.2M$24.8M—

Revenue

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Debt and Equity Securities, Unrealized Gain (Loss)-$15.5M——-$6.2M-$2.5M—